More Research Validates the Benefits of Hospice
New research published in the Journal of the American Medical Association reinforces the benefits of hospice care for patients with cancer facing a poor prognosis. The study, led by Dr. Ziad Obermeyer, a physician at Brigham and Women’s Hospital in Boston, found cancer patients in hospice are less likely to be hospitalized, to be admitted to the intensive care unit, or to undergo invasive procedures. The study included data from nearly 40,000 Medicare patients with cancer who died in 2011.
The study also concludes that healthcare costs in the last year of life were about $9,000 lower per hospice patient. Furthermore, nearly 75% of non-hospice patients in this study died in hospitals or nursing homes, compared to 14% of hospice patients. The authors say their findings highlight the need for frank discussions between physicians and patients about realistic expectations for care at the end of life.
Hospice of Siouxland advocates that physicians have franks discussions with patients about goals of care for end of life and determining treatment options that best meet their goals. “Documenting end of life wishes through advance directives and communication with family members are extremely important to assure the patient’s goals are known and respected," says Linda Todd, Executive Director of Hospice of Siouxland.
The National Hospice and Palliative Care Organization has long supported reimbursement to physicians for facilitating these kind of advanced planning discussions, which is also a key recommendation from the Institute of Medicine in its report “Dying in America”. NHPCO also advocates for concurrent care, a model of healthcare delivery that would not require patients to forgo all curative treatment in order to access hospice services.
“We know that many people access hospice care too late to fully take advantage of all this team-based, patient and family-focused model of care can offer,” says J. Donald Schumacher, PsyD, President and CEO of NHPCO. “While patients with cancer still make up more than a third of all those cared for by hospice providers, their lengths of stay in hospice are among the shortest. This points to the desperate need for clinicians treating cancer to have conversations about palliative care and hospice.”
The publication of this new research in JAMA follows on the heels of the Institute of Medicine report, “Dying in America” and recommendations from the American Medical Association to the Centers for Medicare and Medicaid Services regarding the activation of reimbursement codes to allow Medicare to pay for such conversations. In recent weeks, CMS indicated that the agency intends to solicit additional comments from the public. In the meantime, advance care planning discussions are only reimbursable during the initial ‘Welcome to Medicare’ preventive visit but not for any subsequent annual visit.
“The hospice community continues to be disappointed in Medicare’s lack of leadership in this area,” says Schumacher. “The medical consensus tells us clearly that these end-of-life care conversations are necessary in order for patient wishes to be expressed and honored. Yet, CMS will only reimburse for them when a patient first joins Medicare, typically the healthiest he or she will be as a beneficiary. It defies reason that reimbursement is not available for physicians to take the time for these vital and delicate discussions later on.”